CXCL8 and ovarian carcinoma: Thus, we wanted to determine whether the reduced IL-8 expression and tumor growth in the combination group are associated with decreased levels of S536-phosphorylated p65 and its recruitment to the endogenous IL-8 promoter in ovarian cancer xenografts.